Patent Owner Prevails In Final Written Decision By Patent Board
ALEXANDRIA, Va. — A patent relating to Novartis AG’s Afinitor anti-cancer drug was confirmed as patentable Jan. 11 in a final written decision by the Patent Trial and Appeal Board, which...To view the full article, register now.
Already a subscriber? Click here to view full article